تزریق درون رحمی سلول های تک هسته ای خون محیطی اتولوگ فعال شده با hCG پیامدهای بارداری را در زنان با شکست مکرر لانه گزینی بهبود می بخشد؛ یک کارآزمایی بالینی رندوم شده دو سو کور
Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study
نویسندگان: زهرا پورمقدم , محمدصادق سلطانی زنگبار , گلشن شیخ انصاری , رامیار عزیزی , شادی اقبال فرد , لیلی عاقبتی , شهلا دانایی , محمد حجت فرسنگی , رزا متولی خیاوی , امیر مهدی زاده حقیقی , مهدی یوسفی
کلمات کلیدی: Recurrent implantation failure
Peripheral blood mononuclear cell
Human chorionic gonadotropin
Phosphate buffer saline
T helper 17
Regulatory T cells
نشریه: 18523 , 103182 , 142 , 2020
| نویسنده ثبت کننده مقاله |
مهدی یوسفی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز سلولهای بنیادی |
| کد مقاله |
73381 |
| عنوان فارسی مقاله |
تزریق درون رحمی سلول های تک هسته ای خون محیطی اتولوگ فعال شده با hCG پیامدهای بارداری را در زنان با شکست مکرر لانه گزینی بهبود می بخشد؛ یک کارآزمایی بالینی رندوم شده دو سو کور |
| عنوان لاتین مقاله |
Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study |
| ناشر |
13 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| We aimed to investigate the effect of intrauterine administration of autologous hCG-activated PBMCs in RIF
women with low Th-17/Treg cell ratio. 248 women with a history of implantation failure volunteered to receive
PBMC-therapy. After immunologic consultation and doing flow cytometry analysis, 100 women with at least
three IVF/ET failure who had low Th-17/Treg ratio in comparison with healthy control were enrolled in this
study. These 100 patients were randomly divided into two groups as PBMC receiving (n=50) and controls
(n=50). Then PBMCs were obtained from patients and treated with hCG for 48 h. Afterward, PBMCs were
administered into the uterine cavity of the patient in the study group, two days before ET. The concentration of
inflammatory cytokines was examined in the supernatant of cultured PBMCs after 2, 24, and 48 h of incubation
using the ELISA method. The frequency of Th-17, Treg, and the Th-17/Treg ratio was significantly lower in RIF
women than the healthy controls (P < 0.0001). The secretion of inflammatory cytokines was significantly
higher after 48 h compared to 2 and 24 h (P < 0.0001). The pregnancy and live birth rate were significantly
increased in women undergoing the PBMC-therapy compared to control (PBS-injecting) group (P=0.032 and
P=0.047, respectively). The miscarriage rate was considerably lower in PBMC-therapy group (P=0.029). Our
findings suggest that intrauterine administration of autologous in vitro hCG-activated PBMCs improves pregnancy
outcomes in patients with at least three IVF/ET failures. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Intrauterine administration of.pdf | 1399/06/10 | 1069856 | دانلود |